VWF and blood coagulation disease: Desmopressin acetate (DDAVP) initiates the release of von Willebrand factor and can increase von Willebrand factor and factor VIII levels in normal subjects 3–5 fold.[40] It can be utilized in conjunction with other components in patients with associated coagulopathy.